Xiidra 5% eye drops 5S
Ended Awarded Last action
- Contract number
- SPE2DR26F9NQ3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,532
Award facts
- Contract value 100% obligated
- $10,531.79 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $10,531.79 delivery order to Amerisourcebergen Drug Corp (UEI: KABZK8W6PQT3) on January 29, 2026, for the supply of Xiidra 5% eye drops. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of January 30, 2026, and will be performed at the vendor's location in Conshohocken, Pennsylvania. This award carries no set-aside designation, indicating it was competitively awarded on a full and open basis. Amerisourcebergen Drug Corp operates as a subsidiary of Cencora, Inc., a major pharmaceutical distributor and healthcare solutions provider that serves as a critical vendor for federal medical procurement.
This delivery order is issued under a larger Indefinite Delivery Contract (IDC) vehicle with the DLA Troop Support Medical, valued at up to $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support mechanism enabling Amerisourcebergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including medications, vaccines, and medical devices across multiple therapeutic domains. This delivery order represents a routine pharmaceutical supply transaction fulfilling the military health system's requirements for ophthalmic medication to support Defense Health Agency operations and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F9NQ3?
SPE2DR26F9NQ3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 29, 2026.
How much is contract SPE2DR26F9NQ3 worth?
The government has obligated $10,532 on SPE2DR26F9NQ3.
Is contract SPE2DR26F9NQ3 an order under another contract?
Yes. SPE2DR26F9NQ3 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9NQ3 competed?
The extent of competition for SPE2DR26F9NQ3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award